Results 201 to 210 of about 7,776 (285)

Long-term CSF responses in adult patients with spinal muscular atrophy type 2 or 3 on treatment with nusinersen. [PDF]

J Neurol
Cebulla G, Hai L, Warnken U, Güngör C, Hoffmann DC, Korporal-Kuhnke M, Wildemann B, Wick W, Kessler T, Weiler M.   +9 more
europepmc   +1 more source

Scoliosis in spinal muscular atrophy in the era of disease-modifying therapy: a scoping review. [PDF]

Neurol Sci
Gnazzo M, Pisanò G, Piccolo B, Turco EC, Esposito S, Pera MC.   +5 more
europepmc   +1 more source

The long-term efficacy of nusinersen on respiratory functions in children with symptomatic spinal muscular atrophy type 1. [PDF]

Turk J Med Sci
Kiliç MA, Kürekçi F, Kipoğlu O, Coşkun O, Karacebey BN, Katar S, Avci R, Genç HM, Çakir E, Yildiz EP.   +9 more
europepmc   +1 more source

Functional and structural analysis of SITTER patients with spinal muscular atrophy. [PDF]

Sci Rep
Bieniaszewska A, Sobieska M, Gajewska E.
europepmc   +1 more source

Spontaan spinaal epiduraal hematoom bij acute rugpijn [PDF]

, 2017
Anisau, Aliaksandr, Vangeneugden, Johan, Vanhoenacker, Filip   +2 more
core   +1 more source

Multi-omics profiling in spinal muscular atrophy (SMA): investigating lipid and metabolic alterations through longitudinal CSF analysis of Nusinersen-treated patients. [PDF]

J Neurol
Zandl-Lang M, Züllig T, Holzer M, Eichmann TO, Darnhofer B, Schwerin-Nagel A, Zobel J, Haidl H, Biebl A, Köfeler H, Plecko B.   +10 more
europepmc   +1 more source

Dysregulated balance of D- and L-amino acids modulating glutamatergic neurotransmission in severe spinal muscular atrophy. [PDF]

Neurobiol Dis
Hassan A, di Vito R, Nuzzo T, Vidali M, Carlini MJ, Yadav S, Yang H, D'Amico A, Kolici X, Valsecchi V, Panicucci C, Pignataro G, Bruno C, Bertini E, Errico F, Pellizzoni L, Usiello A.   +16 more
europepmc   +1 more source

Transitioning From Nusinersen to Risdiplam for Spinal Muscular Atrophy in Clinical Practice: A Single-Center Experience. [PDF]

Muscle Nerve
Bekircan-Kurt CE, Subramanian S, Chagat S, Mackenzie SJ, Iammarino M, Reash N, Richardson C, Tsao CY, Noritz G, Gushue C, Kotha K, Paul G, Shell R, Alfano LN, Lowes LP, Connolly AM, Waldrop MA.   +16 more
europepmc   +1 more source

Long-Term Dynamics of CSF and Serum Neurofilament Light Chain in Adult Patients With 5q Spinal Muscular Atrophy Treated With Nusinersen. [PDF]

Neurology
Cordts I, Fuetterer C, Wachinger A, von Heynitz R, Kessler T, Freigang M, Quinten AL, Bjelica B, Brakemeier S, Hobbiebrunken E, Hagenacker T, Petri S, Koch JC, Hahn A, Lingor P, Deschauer M, Günther R, Weiler M, Haller B, Feneberg E.   +19 more
europepmc   +1 more source

Real-world outcomes of spinal muscular atrophy treatment with onasemnogene abeparvovec in Croatia: a comprehensive case series and literature review. [PDF]

Front Med (Lausanne)
Lehman I, Matošević M, Lamot L, Bunoza B.   +3 more
europepmc   +1 more source